Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors
Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors have?
Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors has 189 citations in the OpenAlex counts ScholarIQ stores.
When was Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors published?
Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors has 2011 year in the ScholarIQ index.
What is the open-access status of Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors?
Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors has bronze oa status in the ScholarIQ index.
What is the DOI of Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors?
The DOI for Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors is on the source record.
What is the PMID of Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors?
The PMID for Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors is on the source record.
What is the OpenAlex record for Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors?
The OpenAlex for Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors is on the source record.